Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Choline: The Neurocognitive Essential Nutrient of Interest to Obstetricians and Gynecologists.

Wallace TC, Blusztajn JK, Caudill MA, Klatt KC, Zeisel SH.

J Diet Suppl. 2019 Aug 6:1-20. doi: 10.1080/19390211.2019.1639875. [Epub ahead of print]

PMID:
31385730
2.

Choline: The Underconsumed and Underappreciated Essential Nutrient.

Wallace TC, Blusztajn JK, Caudill MA, Klatt KC, Natker E, Zeisel SH, Zelman KM.

Nutr Today. 2018 Nov-Dec;53(6):240-253. doi: 10.1097/NT.0000000000000302. Epub 2018 Nov 13.

3.

Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Adams SL, Benayoun L, Tilton K, Mellott TJ, Seshadri S, Blusztajn JK, Delalle I.

J Alzheimers Dis. 2018;63(4):1433-1443. doi: 10.3233/JAD-171065.

4.

Corrigendum to "Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease" [Brain Res. 1681 (2018) 34-43].

Carreras I, Aytan N, Mellott T, Choi JK, Lehar M, Crabtree L, Leite-Morris K, Jenkins BG, Blusztajn JK, Dedeoglu A.

Brain Res. 2018 Jun 1;1688:113-115. doi: 10.1016/j.brainres.2018.03.005. Epub 2018 Mar 12. No abstract available.

PMID:
29526415
5.

Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease.

Aytan N, Choi JK, Carreras I, Crabtree L, Nguyen B, Lehar M, Blusztajn JK, Jenkins BG, Dedeoglu A.

Eur J Pharmacol. 2018 Jun 5;828:9-17. doi: 10.1016/j.ejphar.2018.02.045. Epub 2018 Mar 3.

6.

Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.

Tao Q, Zhu H, Chen X, Stern RA, Kowall N, Au R, Blusztajn JK, Qiu WQ; Alzheimer’s Disease Metabolomics Consortium.

J Alzheimers Dis. 2018;62(2):597-609. doi: 10.3233/JAD-170948.

7.

Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease.

Carreras I, Aytan N, Mellott T, Choi JK, Lehar M, Crabtree L, Leite-Morris K, Jenkins BG, Blusztajn JK, Dedeoglu A.

Brain Res. 2018 Feb 15;1681:34-43. doi: 10.1016/j.brainres.2017.12.030. Epub 2017 Dec 24. Erratum in: Brain Res. 2018 Mar 8;:.

8.

Neuroprotective Actions of Dietary Choline.

Blusztajn JK, Slack BE, Mellott TJ.

Nutrients. 2017 Jul 28;9(8). pii: E815. doi: 10.3390/nu9080815. Review.

9.

Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Adams SL, Benayoun L, Tilton K, Chavez OR, Himali JJ, Blusztajn JK, Seshadri S, Delalle I.

J Alzheimers Dis. 2017;60(1):43-56. doi: 10.3233/JAD-170459.

10.

Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.

Guo S, Lai C, Wu C, Cen G; Alzheimer's Disease Neuroimaging Initiative.

Front Aging Neurosci. 2017 May 18;9:146. doi: 10.3389/fnagi.2017.00146. eCollection 2017. Erratum in: Front Aging Neurosci. 2017 Sep 05;9:293.

11.

Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.

Wang E, Zhu H, Wang X, Gower AC, Wallack M, Blusztajn JK, Kowall N, Qiu WQ.

J Alzheimers Dis. 2017;56(1):47-61. doi: 10.3233/JAD-160677.

12.

Comment on "Multiple repressive mechanisms in the hippocampus during memory formation".

Mathew RS, Mullan H, Blusztajn JK, Lehtinen MK.

Science. 2016 Jul 29;353(6298):453.

13.

Intrinsic Cholinergic Neurons in the Hippocampus: Fact or Artifact?

Blusztajn JK, Rinnofner J.

Front Synaptic Neurosci. 2016 Mar 10;8:6. doi: 10.3389/fnsyn.2016.00006. eCollection 2016.

14.

High maternal choline consumption during pregnancy and nursing alleviates deficits in social interaction and improves anxiety-like behaviors in the BTBR T+Itpr3tf/J mouse model of autism.

Langley EA, Krykbaeva M, Blusztajn JK, Mellott TJ.

Behav Brain Res. 2015 Feb 1;278:210-20. doi: 10.1016/j.bbr.2014.09.043. Epub 2014 Oct 6.

PMID:
25300468
15.

IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.

Mellott TJ, Pender SM, Burke RM, Langley EA, Blusztajn JK.

PLoS One. 2014 Apr 14;9(4):e94287. doi: 10.1371/journal.pone.0094287. eCollection 2014.

16.

BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.

Burke RM, Norman TA, Haydar TF, Slack BE, Leeman SE, Blusztajn JK, Mellott TJ.

Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19567-72. doi: 10.1073/pnas.1319297110. Epub 2013 Nov 11.

17.

Neuroprotective actions of perinatal choline nutrition.

Blusztajn JK, Mellott TJ.

Clin Chem Lab Med. 2013 Mar 1;51(3):591-9. doi: 10.1515/cclm-2012-0635. Review.

18.

Choline nutrition programs brain development via DNA and histone methylation.

Blusztajn JK, Mellott TJ.

Cent Nerv Syst Agents Med Chem. 2012 Jun;12(2):82-94. Review.

19.

BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons.

Schnitzler AC, Mellott TJ, Lopez-Coviella I, Tallini YN, Kotlikoff MI, Follettie MT, Blusztajn JK.

J Neurosci. 2010 Jun 16;30(24):8221-8. doi: 10.1523/JNEUROSCI.5611-09.2010.

20.

Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival.

Kovacheva VP, Davison JM, Mellott TJ, Rogers AE, Yang S, O'Brien MJ, Blusztajn JK.

FASEB J. 2009 Apr;23(4):1054-63. doi: 10.1096/fj.08-122168. Epub 2008 Dec 1.

Supplemental Content

Loading ...
Support Center